-
EP3142698
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3142698
| EP3142698 - IMMUNOTHERAPY WITH BINDING AGENTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.06.2020 Database last updated on 19.07.2024 | |
| Former | Request for examination was made Status updated on 17.02.2017 | ||
| Former | The international publication has been made Status updated on 01.11.2016 | Most recent event Tooltip | 26.06.2020 | Application deemed to be withdrawn | published on 29.07.2020 [2020/31] | Applicant(s) | For all designated states Oncomed Pharmaceuticals, Inc. 800 Chesapeake Drive Redwood City, CA 94063-4748 / US | [2017/12] | Inventor(s) | 01 /
GURNEY, Austin, L. 949 Diamond Street San Francisco, CA 94114 / US | 02 /
XIE, Ming-hong 416 Biscayne Avenue Foster City, CA 94404 / US | 03 /
PORTER, James, Gordon 7261 Dumas Place Newark, CA 94560 / US | [2017/12] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [N/P] |
| Former [2017/12] | Sutcliffe, Nicholas Robert, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | Application number, filing date | 15791992.9 | 13.05.2015 | [2017/12] | WO2015US30472 | Priority number, date | US201461992456P | 13.05.2014 Original published format: US 201461992456 P | [2017/12] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2015175599 | Date: | 19.11.2015 | Language: | EN | [2015/46] | Type: | A2 Application without search report | No.: | EP3142698 | Date: | 22.03.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 19.11.2015 takes the place of the publication of the European patent application. | [2017/12] | Search report(s) | International search report - published on: | US | 07.01.2016 | (Supplementary) European search report - dispatched on: | EP | 09.02.2018 | Classification | IPC: | A61K39/395, C07K16/00, C12N5/07 | [2017/12] | CPC: |
C07K16/2803 (EP,US);
C07K14/70503 (US);
C07K16/2818 (US);
C07K16/30 (US);
A61K2039/505 (US);
A61K38/00 (EP,US);
C07K2317/76 (US);
C07K2319/30 (EP,US);
C07K2319/32 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/12] | Extension states | BA | 15.11.2016 | ME | 15.11.2016 | Title | German: | IMMUNTHERAPIE MIT BINDEMITTELN | [2017/12] | English: | IMMUNOTHERAPY WITH BINDING AGENTS | [2017/12] | French: | IMMUNOTHÉRAPIE À L'AIDE D'AGENTS DE LIAISON | [2017/12] | Entry into regional phase | 15.11.2016 | National basic fee paid | 15.11.2016 | Search fee paid | 15.11.2016 | Designation fee(s) paid | 15.11.2016 | Examination fee paid | Examination procedure | 01.11.2016 | Date on which the examining division has become responsible | 15.11.2016 | Examination requested [2017/12] | 22.08.2018 | Amendment by applicant (claims and/or description) | 03.12.2019 | Application deemed to be withdrawn, date of legal effect [2020/31] | 14.01.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2020/31] | Fees paid | Renewal fee | 10.05.2017 | Renewal fee patent year 03 | 11.05.2018 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.05.2019 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI] - "RecName: Full=V-set and transmembrane domain-containing protein 4; Contains: RecName: Full=Peptide Lv; Flags: Precursor;", UniProt, (20070206), Database accession no. Q8IW00, URL: EBI, XP002777467 [X] 4,8-10 * abstract * [I] 1-3 | [A] - D. DANGAJ ET AL, "Novel Recombinant Human B7-H4 Antibodies Overcome Tumoral Immune Escape to Potentiate T-Cell Antitumor Responses", CANCER RESEARCH, (20130530), vol. 73, no. 15, doi:10.1158/0008-5472.CAN-12-3457, ISSN 0008-5472, pages 4820 - 4829, XP055122936 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1158/0008-5472.CAN-12-3457 | International search | [X]US2004067882 (ALSOBROOK JOHN P [US], et al) [X] 1-7 * para [0032], [0164], [0165], Tables 19C, 19E, SEQ ID NO: 76 * |